The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain.

The NIH funding will help address a "traditional barrier" to health care, says Elizabeth Evans, professor of community health ...

Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.

Shionogi now plans to accelerate its expansion in Europe and the U.S., while pursuing full-scale growth of its new drug ...

There were still 32,000 new cases of HIV in the U.S. in 2022. And about thousands of people still die annually from AIDS. HIV ...

WHO has sounded alarm over a sharp spike in HIV cases in the Philippines, Fiji and Papua New Guinea, urging urgent prevention ...

Addressing the question of whether and how immune cells (macrophages) in the central nervous system (CNS) traffic out, ...

Leaders in HIV research highlighted the critical role of that research has played in advancing HIV science over the past 40 years. In a commentary in Nature Medicine, they explained how U.S.-funded ...

The Health departmental officials said that “a new plan will be shared" for when the funding ends in March 2026.

Len is for HIV-negative people to try and stop them from getting HIV…when you get an injection, the contents of the injection ...

A University of Massachusetts Amherst public health researcher has received four grants totaling $17.9 million from the ...